Douglas R. Spitz

28.5k total citations · 6 hit papers
300 papers, 22.1k citations indexed

About

Douglas R. Spitz is a scholar working on Molecular Biology, Cancer Research and Nutrition and Dietetics. According to data from OpenAlex, Douglas R. Spitz has authored 300 papers receiving a total of 22.1k indexed citations (citations by other indexed papers that have themselves been cited), including 162 papers in Molecular Biology, 50 papers in Cancer Research and 35 papers in Nutrition and Dietetics. Recurrent topics in Douglas R. Spitz's work include Glutathione Transferases and Polymorphisms (47 papers), Cancer, Hypoxia, and Metabolism (37 papers) and Redox biology and oxidative stress (36 papers). Douglas R. Spitz is often cited by papers focused on Glutathione Transferases and Polymorphisms (47 papers), Cancer, Hypoxia, and Metabolism (37 papers) and Redox biology and oxidative stress (36 papers). Douglas R. Spitz collaborates with scholars based in United States, Canada and Jordan. Douglas R. Spitz's co-authors include Larry W. Oberley, David Gius, Nükhet Aykin‐Burns, Iman M. Ahmad, Mitchell C. Coleman, Julia Sim, Edouard I. Azzam, Jian Jian Li, Garry R. Buettner and Bryan G. Allen and has published in prestigious journals such as Nature, Cell and Journal of Biological Chemistry.

In The Last Decade

Douglas R. Spitz

292 papers receiving 21.7k citations

Hit Papers

A Dynamic Pathway for Calcium-Independent... 1989 2026 2001 2013 2008 2010 1989 2010 2020 250 500 750

Peers

Douglas R. Spitz
Larry W. Oberley United States
Valerian E. Kagan United States
James K. Liao United States
Lawrence J. Marnett United States
Robert E. Gerszten United States
Zheng Dong United States
Douglas R. Spitz
Citations per year, relative to Douglas R. Spitz Douglas R. Spitz (= 1×) peers Shinya Toyokuni

Countries citing papers authored by Douglas R. Spitz

Since Specialization
Citations

This map shows the geographic impact of Douglas R. Spitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas R. Spitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas R. Spitz more than expected).

Fields of papers citing papers by Douglas R. Spitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas R. Spitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas R. Spitz. The network helps show where Douglas R. Spitz may publish in the future.

Co-authorship network of co-authors of Douglas R. Spitz

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas R. Spitz. A scholar is included among the top collaborators of Douglas R. Spitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas R. Spitz. Douglas R. Spitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Geasland, Katharine, et al.. (2025). Mitochondrial oxidants promote platelet activation and thrombotic susceptibility in prediabetes. Journal of Clinical Investigation. 136(4).
2.
Fath, Melissa A., Charles Searby, Jeffrey M. Stolwijk, et al.. (2023). Depletion of Labile Iron Induces Replication Stress and Enhances Responses to Chemoradiation in Non-Small-Cell Lung Cancer. Antioxidants. 12(11). 2005–2005. 7 indexed citations
3.
Sonkar, Vijay K., Alicia S. Eustes, Azaj Ahmed, et al.. (2022). Endogenous SOD2 (Superoxide Dismutase) Regulates Platelet-Dependent Thrombin Generation and Thrombosis During Aging. Arteriosclerosis Thrombosis and Vascular Biology. 43(1). 79–91. 29 indexed citations
4.
Zhang, Chunyun, Michael L. McCormick, Douglas R. Spitz, et al.. (2021). The Effects of Benoxacor on the Liver and Gut Microbiome of C57BL/6 Mice. Toxicological Sciences. 186(1). 102–117. 6 indexed citations
5.
O’Leary, Brianne R., Juan Du, Ehab H. Sarsour, et al.. (2020). Dual Oxidase-Induced Sustained Generation of Hydrogen Peroxide Contributes to Pharmacologic Ascorbate-Induced Cytotoxicity. Cancer Research. 80(7). 1401–1413. 30 indexed citations
6.
Park, Julien H., Janine Reunert, Michael L. McCormick, et al.. (2019). SOD1 deficiency: a novel syndrome distinct from amyotrophic lateral sclerosis. Brain. 142(8). 2230–2237. 62 indexed citations
7.
Alexander, Matthew S., Justin G. Wilkes, Garry R. Buettner, et al.. (2018). Pharmacologic Ascorbate Reduces Radiation-Induced Normal Tissue Toxicity and Enhances Tumor Radiosensitization in Pancreatic Cancer. Cancer Research. 78(24). 6838–6851. 89 indexed citations
8.
Rashmi, Ramachandran, Xiaojing Huang, John M. Floberg, et al.. (2018). Radioresistant Cervical Cancers Are Sensitive to Inhibition of Glycolysis and Redox Metabolism. Cancer Research. 78(6). 1392–1403. 68 indexed citations
9.
Mapuskar, Kranti A., Kyle H. Flippo, Joshua D. Schoenfeld, et al.. (2017). Mitochondrial Superoxide Increases Age-Associated Susceptibility of Human Dermal Fibroblasts to Radiation and Chemotherapy. Cancer Research. 77(18). 5054–5067. 31 indexed citations
10.
Du, Juan, John A. Cieslak, Jessemae L. Welsh, et al.. (2015). Pharmacological Ascorbate Radiosensitizes Pancreatic Cancer. Cancer Research. 75(16). 3314–3326. 89 indexed citations
11.
O’Leary, Brianne R., Melissa A. Fath, Andrew M. Bellizzi, et al.. (2015). Loss of SOD3 (EcSOD) Expression Promotes an Aggressive Phenotype in Human Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research. 21(7). 1741–1751. 57 indexed citations
12.
Allen, Bryan G., Sudershan K. Bhatia, John M. Buatti, et al.. (2013). Ketogenic Diets Enhance Oxidative Stress and Radio-Chemo-Therapy Responses in Lung Cancer Xenografts. Clinical Cancer Research. 19(14). 3905–3913. 178 indexed citations
13.
Bey, Erik A., Kathryn E. Reinicke, Melissa C. Srougi, et al.. (2013). Catalase Abrogates β-Lapachone–Induced PARP1 Hyperactivation–Directed Programmed Necrosis in NQO1-Positive Breast Cancers. Molecular Cancer Therapeutics. 12(10). 2110–2120. 84 indexed citations
14.
Duru, Nadire, Ming Fan, Demet Candas, et al.. (2012). HER2-Associated Radioresistance of Breast Cancer Stem Cells Isolated from HER2-Negative Breast Cancer Cells. Clinical Cancer Research. 18(24). 6634–6647. 169 indexed citations
15.
Love-Homan, Laurie, et al.. (2012). Susceptibility of Human Head and Neck Cancer Cells to Combined Inhibition of Glutathione and Thioredoxin Metabolism. PLoS ONE. 7(10). e48175–e48175. 63 indexed citations
16.
Fath, Melissa A., et al.. (2011). Enhancement of Carboplatin-Mediated Lung Cancer Cell Killing by Simultaneous Disruption of Glutathione and Thioredoxin Metabolism. Clinical Cancer Research. 17(19). 6206–6217. 100 indexed citations
17.
Erickson, Jeffrey R., Mei-ling A. Joiner, Xiaoqun Guan, et al.. (2008). A Dynamic Pathway for Calcium-Independent Activation of CaMKII by Methionine Oxidation. Cell. 133(3). 462–474. 881 indexed citations breakdown →
18.
Li, Ling, et al.. (2005). The Role of Low Molecular Weight Thiols in T Lymphocyte Proliferation and IL-2 Secretion. The Journal of Immunology. 175(12). 7965–7972. 72 indexed citations
19.
Bradbury, C. Matthew, Douglas R. Spitz, & David Gius. (2001). Thioredoxin reductase is a novel cytoplasmic signaling factor regulating radiation-induced AP-1 DNA-binding activity and gene expression via active cysteine residues. Free Radical Biology and Medicine. 31(10). 128. 1 indexed citations
20.
Oberley, Larry W. & Douglas R. Spitz. (1984). [61] Assay of superoxide dismutase activity in tumor tissue. Methods in enzymology on CD-ROM/Methods in enzymology. 105. 457–464. 378 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026